An evaluation of molecular markers that predict maximal surgical cytoreduction: A Gynecologic Oncology Group trial

Journal article

Peer reviewed

C. Miller, A. Miller, C. Hamilton, A. Alvarez-Secord, L. Havrilesky, F. Muggia and J. Farley

Gynecologic oncology, Vol.130(1), pp.e20-e20

07/2013

Metrics

4 Record Views

Title: An evaluation of molecular markers that predict maximal surgical cytoreduction: A Gynecologic Oncology Group trial
Creators: C. Miller - San Antonio Military Medical Center
A. Miller - Roswell Park Cancer Institute
C. Hamilton - Walter Reed National Military Medical Center
A. Alvarez-Secord - Duke Medical Center
L. Havrilesky - Duke Medical Center
F. Muggia - New York University Medical Center, New York, NY.
J. Farley - St. Joseph's Hospital and Medical Center
Publication Details: Gynecologic oncology, Vol.130(1), pp.e20-e20
Publisher: Elsevier Inc
Identifiers: 991005969027102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article